Common issues with semaglutide include feeling sick, feeling full, constipation, diarrhea and vomiting
Type 2 diabetes drug Ozempic continues to make headlines
Avoid use of phentermine and topiramate extended-release capsules in patients with end-stage renal disease on dialysis
In rat coronary artery smooth muscle cells, treatment with liraglutide inhibited VSMC phenotypic transition induced by advanced glycation end products (AGEs), through blocking the nuclear factor-B (NF-B) signaling pathway and activating the protein kinase A (PKA) signaling pathway
In the SURMOUNT clinical trials for tirzepatide (Mounjaro/Zepbound), a small but statistically significant percentage of participants reported insomnia as an adverse event compared to the placebo group
These contraindications are treated as standard screening criteria across the growth-factor research literature, not unique cautions specific to a single study